Medical Review Policy
Peptide science intersects with human health. This policy describes how we vet health-related claims, grade evidence quality, and maintain the integrity of medical information across MVP Peptides.
Important Disclaimer
MVP Peptides is an educational resource, not a medical provider. Nothing on this website constitutes medical advice. All health-related content is intended for informational and research purposes only. Always consult a qualified healthcare professional before making any health decisions.
How We Review Medical Claims
1. Source Identification
Every health-related claim must be traceable to at least one peer-reviewed study. We identify the specific paper, verify its publication in a recognized journal, and confirm it has not been retracted.
2. Evidence Level Assessment
Each supporting study is classified by evidence strength. We assess whether the research was conducted in humans or animal models, the study design (randomized controlled trial, cohort study, case report), sample size, and whether results have been replicated.
3. Claim Calibration
Language is carefully calibrated to match the evidence. Preclinical findings are described as "research suggests" or "animal studies indicate," while strong human trial data may use "clinical evidence demonstrates." We never overstate conclusions beyond what the cited evidence supports.
4. Limitations Disclosure
Where relevant, we note study limitations: small sample sizes, lack of human trials, conflicts of interest, or preliminary nature of the findings. Transparency about what we do not yet know is as important as presenting what we do.
Evidence Grading Methodology
We assign one of four evidence grades to health-related claims across our content. These grades help readers quickly assess the strength of the supporting research.
Strong Evidence
Supported by multiple randomized controlled trials (RCTs) in humans, systematic reviews, or meta-analyses. Results are consistent and reproducible. Examples: semaglutide for weight management, insulin for blood glucose regulation.
Moderate Evidence
Supported by at least one human clinical trial or multiple well-designed observational studies. Results are promising but may have limitations such as small sample sizes or short follow-up periods.
Emerging Evidence
Based on early-phase human trials, pilot studies, or strong mechanistic evidence from animal models with plausible human relevance. Results are encouraging but require further validation.
Preclinical Evidence
Based exclusively on animal studies, in-vitro experiments, or computational models. While these findings inform research directions, they have not been validated in human subjects. Results should not be extrapolated to human health outcomes.
Topics Under Special Scrutiny
Certain content areas receive additional editorial oversight due to their potential impact on reader health decisions:
- Dosing information — always presented as research context, never as personal recommendations. Accompanied by a disclaimer.
- Side effects and contraindications — never minimized or omitted. Listed prominently on every peptide detail page.
- Drug interactions — noted when documented in the literature. Readers are directed to consult healthcare providers.
- Off-label or unapproved uses — clearly labeled as such, with the FDA regulatory status noted.
- Stacking protocols — framed as research-context information, not instructions, with safety considerations highlighted.
Conflict of Interest Disclosure
MVP Peptides may earn affiliate commissions from vendor links on certain pages. This commercial relationship is always disclosed via a visible affiliate notice on those pages. Our editorial and medical review processes are independent of these relationships:
- Affiliate status never influences which peptides are covered or how they are reviewed.
- Vendor recommendations are based on third-party testing, purity verification, and customer feedback—not commission rates.
- Educational content pages (topics, glossary, safety guides) contain no affiliate links.
Report a Concern
If you believe any medical claim on our site is inaccurate, misleading, or inadequately sourced, we want to hear from you. All reports are reviewed promptly.